Respiratory Elizabethkingia Genomic and Resistance Data from a Tertiary Hospital

18 Elizabethkingia isolates from 16 patients at a tertiary pulmonary hospital between 2024 and 2025 were analyzed. Whole-genome sequencing provided species identification, pangenome analysis, and phylogenetic reconstruction. Antimicrobial susceptibility testing and molecular docking were performed to characterize resistance mechanisms.

Use Cases

• Analyzing phylogenetic relationships and potential nosocomial transmission based on core-genome SNP data
• Investigating fluoroquinolone resistance mechanisms based on GyrA mutation analysis
• Evaluating antimicrobial susceptibility patterns across bacterial isolates
• Studying pangenome structure and genomic diversity of clinical isolates

Strengths

• Includes 18 isolates with whole-genome sequencing data
• Provides antimicrobial susceptibility results for multiple drug classes
• Integrates genomic analysis with structural modeling of resistance mutations

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download
• Data is from a single hospital and a short time period (2024-2025), limiting generalizability

Provenance

Source

Yongpeng Shang

Collection Method

Clinical isolates collected from a tertiary pulmonary hospital, analyzed via whole-genome sequencing and VITEK® 2 system testing.

Time Range

2024-2025

Freshness

Last updated 2026-04-10 06:03:23